Yujiro S. Hata - 12 Apr 2023 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
President and CEO, Director
Signature
/s/ Jason Throne, as Attorney-in-Fact for Yujiro Hata
Issuer symbol
IDYA
Transactions as of
12 Apr 2023
Net transactions value
+$50,000
Form type
4
Filing time
13 Apr 2023, 16:11:27 UTC
Previous filing
06 Mar 2023
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDYA Common Stock Options Exercise $50,000 +11,601 +1.7% $4.31* 677,887 12 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Options Exercise $0 -11,601 -2.4% $0.000000 474,454 12 Apr 2023 Common Stock 11,601 $4.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are fully vested and exercisable.